Lobbyist information

Amount

Jan Z. Rose	$162,215.00
Employed Terminated 01/01/2024

Stephen V. Miller	$70,000.00
Employed Terminated 01/01/2024

Terence P. McDermott	$208,000.00
Employed Terminated 01/01/2024

William P. McDermott	$449,440.00
Employed Terminated 01/01/2024

Total salaries paid:      $889,655.00

Client information

Amount

Bristol Myers Squibb Company	$60,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2024 Healthcare, Pharmaceuticals

CSX Transportation, Inc	$72,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2024 All legislation related to freight and passenger rail.

Dana-Farber Cancer Institute, Inc.

$90,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2024 Any & all legislation & regulations including but not limited to hospitals, healthcare systems, health care reform & access, wellness & prevention, cancer, palliative care, prescribing and dispensing, survivorship, implementation of Chapter 224 the Acts of 2012. Any & all legislation, regulation, policy matters before the legislature or executive branch including the Executive Offices of the Governor and Lieutenant Governor, Executive Office of Health and Human Services (EOHHS), Department of Public Health (DPH), Division of Insurance (DOI), MassHealth & related matters to the Attorney General (AG), Center for Health Information and Analysis (CHIA) and the Massachusetts Health Policy Commission (HPC)

Mallinckrodt, LLC	$66,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2024 All matters related to healthcare and pharmaceutical manufacturing.

Massachusetts Biotechnology Council, Inc.

$120,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2024 Any and all legislation and regulations pertaining to the healthcare system; Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth; implementation of Chapter 224 the Acts of 2012, health care reform, drug innovation, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing related policies, Massachusetts Life Sciences Center, research and development, taxation policies, drug safety, recycling and disposal policies green bio policies. Any and all legislation, regulation, policy matters before the legislature or executive branch including the Executive Offices of the Governor and Lieutenant Governor, Executive Office of Health & Human Services, Department of Public Health, Division of Insurance, MassHealth and related matters to the Office of the Attorney General, Center for Health Information and Analysis and the Health Policy Commission.

Merck Sharp & Dohme LLC	$56,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2024 Pharmaceutical and Healthcare

Nellie Mae Education Foundation Inc	$66,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2024 Legislation and regulations pertaining to Directors and CEO's of public charities

New England Baptist Hospital

$47,800.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2024 Any and all legislation and regulations including but not limited to hospitals, healthcare systems, healthcare reform, health care access, wellness and prevention, implementation of Chapter 224 the Acts of 2012. Any and all legislation, regulation, policy matters before the legislature or executive branch including not limited to the Executive Offices of the Governor and Lieutenant Governor, Executive Office of Health and Human Services (EOHHS), Department of Public Health (DPH), Division of Insurance (DOI), MassHealth & related matters to the Attorney General (AG), Center for Health Information and Analysis (CHIA) and the Massachusetts Health Policy Commission (HPC)

New England Physical Therapy Network, P.C.	$15,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2024 Advocacy related to reimbursement issues pertaining to healthcare.

Sumitomo Pharma America, Inc.

$14,775.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2024 03/31/2024 Any and all legislation and regulations pertaining to healthcare systems; any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; any laws or regulations that impose or levy taxes upon a biopharmaceutical company doing business in the Commonwealth; any laws or regulations which provided incentives or disincentives to biopharmaceutical companies conducting research and development in the Commonwealth.

Tufts Medicine, Inc.	$72,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2024 Legislative and executive advocacy on issues related to healthcare in the Commonwealth of Massachusetts.

Wine & Spirit Wholesalers of Massachusetts, Inc.	$210,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2024 All legislation and regulations affecting the alcohol distribution, licensing and sale in MA

Total salaries received:      $889,575.00

Expenditures

Amount